Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|7|1038-1049

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.7, 2011-03, pp. : 1038-1049

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synergistic Cytotoxic Activity of Recombinant TRAIL Plus the Non-Genotoxic Activator of the p53 Pathway Nutlin-3 in Acute Myeloid Leukemia Cells

By  

Current Drug Metabolism, Vol. 8, Iss. 4, 2007-05 ,pp. : 395-403

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecules Targeting p53 to Improve Antitumor Therapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-08 ,pp. : 856-868

Bentham Science Publishers

Access to resources Recommend Favorite

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 749-772

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide Activators of the p53 Tumor Suppressor

By  

Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. : 603-609

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Genotoxic Assessment of a Natural Antimicrobial Agent: Squalamine

By Alhanout Kamel   Giorgio Carole D.   Meo Michel D.   Brunel Jean M.  

Anti-Infective Agents, Vol. 12, Iss. 1, 2014-01 ,pp. : 75-79

Bentham Science Publishers

Access to resources Recommend Favorite